CPhi Preview 2013: Pfizer

Article

2013 CPhI Exhibitor Preview

Company: Pfizer CentreSource

Description: Pfizer CentreSource (PCS) integrates Pfizer’s world-class analytical, regulatory, technical support and production expertise to provide greater flexibility and help third-party customers work in accelerated timeframes.  Key manufacturing assets include world-class bioprocessing facilities in the United States and Europe, as well as high-containment capabilities in Europe. PCS also offers specialty dosage form manufacturing and an array of active pharmaceutical ingredients and  fine chemical intermediates.

Website: www.pfizercentresource.com

Booth Number: 30D54

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Benuvia Granted GMP Certification by Brazil National Health Surveillance Agency

Patrick Lavery
March 14th 2025
Article

The certification allows Benuvia to produce pharmaceutical products for companies, either local to Brazil or international, that may be looking for compliant and high-quality production capabilities in the Brazilian pharmaceutical market.

Drug Solutions Podcast: Forecasting Pharma’s Future

Drug Solutions Podcast: Forecasting Pharma’s Future

Felicity Thomas
January 31st 2025
Podcast

This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

IL Group Previews Packaging Safety Solutions to be Shown at INTERPHEX

Patrick Lavery
March 14th 2025
Article

The company’s US entity, Iwata Label USA, will exhibit its Vial Protect Pack, Light Protect Pack, and Shrink Tack Label.

Drug Solutions Podcast: Realizing AI’s Potential

Drug Solutions Podcast: Realizing AI’s Potential

Felicity Thomas
December 20th 2024
Podcast

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

Sun Pharma Agrees to Acquire Checkpoint Therapeutics

Patrick Lavery
March 12th 2025
Article

The transaction includes Unloxcyt (cosibelimab-ipdl), which was approved by FDA in December 2024 for treatment of adults with cutaneous squamous cell carcinoma (cSCC).

concept of industry 4 0 technology automation system with cloud computing | Image Credit: © Sasirat - © Sasirat - stock.adobe.com

Accelerating Adoption of Smart Tools to Advance Manufacturing

Feliza Mirasol
March 12th 2025
Article

Industry 4.0 is driving adoption in the pharma industry for smart equipment and tools that will advance manufacturing.